2 citations
,
May 2022 in “JAAD Case Reports” This review discusses the onset and characteristics of telogen effluvium following SARS-CoV-2 infection, implicating stress, cytokine release, or viral damage, and reports no new clinical results.
August 2024 in “Journal of Vaccines Immunology and Immunopathology” In this case study, the researchers investigated a 44-year-old woman who developed rapidly progressing alopecia universalis after receiving a COVID-19 vaccine, and reviewed existing literature to explore potential links between COVID-19 vaccines and autoimmune hair loss conditions like alopecia areata and universalis.
October 2023 in “Journal of Pakistan Association of Dermatologists” In this case report, a 33-year-old woman with severe post-COVID alopecia areata experienced hair regrowth after two months of treatment with topical minoxidil, tacrolimus, and scalp PRP with micro-needling, though some bald patches reoccurred.
8 citations
,
January 2022 in “Cureus” This case study reports a patient with post-COVID-19 diffuse alopecia who experienced gradual hair recovery to near pre-infection levels within seven months.
This report details a case of severe alopecia areata developing one month after COVID-19 infection in a 20-year-old woman, suggesting a possible connection between COVID-19 and the condition's onset.